Company intelligence / Profile preview
Biogenera SpA
Ozzano dell'Emilia, Emilia-Romagna, Italybiogenera.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Biogenera SpA develops patient-specific, DNA-based biotechnological medicines using its proprietary MyGenera™ platform. The lead candidate, BGA002, targets pediatric neuroblastoma and soft tissue sarcomas and has received Orphan Drug status from the European Medicines Agency. Preclinical studies show promise against aggressive adult cancers as well. The company collaborates with academic institutions such as the University of Bologna to expand its pipeline of gene-targeted therapies for oncology and other severe diseases with high unmet needs.
- Therapeutic areas
- Oncology
- Modalities
- DNA-based therapeutics (gene-specific oligonucleotides)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
03
Partnerships
Collaborations with universities including University of BolognaPartnerships with pharmaceutical companies (not specifically named)
Beyond the preview
Go deeper on Biogenera SpA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biogenera SpA.